Cargando…
Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus
BACKGROUND: Various inflammatory biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), have been well authenticated to predict clinical outcomes in numerous types of cancer. The optimal treatment for patients with locally advanced esophageal squamous ce...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872927/ https://www.ncbi.nlm.nih.gov/pubmed/33574705 http://dx.doi.org/10.2147/CMAR.S294344 |
_version_ | 1783649284307025920 |
---|---|
author | Wang, Chen Tong, Jiaqi Tang, Mengqiu Lu, Yunyun Liang, Gaofeng Zhang, Zhanchun Chen, Tian |
author_facet | Wang, Chen Tong, Jiaqi Tang, Mengqiu Lu, Yunyun Liang, Gaofeng Zhang, Zhanchun Chen, Tian |
author_sort | Wang, Chen |
collection | PubMed |
description | BACKGROUND: Various inflammatory biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), have been well authenticated to predict clinical outcomes in numerous types of cancer. The optimal treatment for patients with locally advanced esophageal squamous cell carcinoma (ESCC) located in the middle or upper region is still inconclusive. The aim of the study was to examine pretreatment NLR and PLR to select from radical surgery or definitive chemoradiotherapy (dCRT) for these patients. The linkage between pretreatment NLR/PLR and prognosis was also analyzed. METHODS: NLR and PLR were calculated in 113 locally advanced ESCC located in the middle or upper esophagus of patients who underwent radical surgery or dCRT between January 2014 and December 2019. A receiver operating characteristic curve was plotted to select the best cut-off value of NLR and PLR for predicting survival. A survival curve was plotted using the Kaplan–Meier method. Univariate and multivariate Cox regression analyses were applied to assess predictors for survival. RESULTS: NLR and PLR were associated with the extent of lymph node metastasis (NLR: P = 0.045; PLR: P = 0.002). Additionally, high PLR and recurrence with distant organ metastasis were closely related (P = 0.014), and NLR was related to the tumor stage (P = 0.043). The results of the multivariate analysis revealed that NLR (>2.07) and PLR (>183.06) were independently associated with poor prognosis. It is noteworthy that surgery was associated with a superior OS compared with dCRT in the low NLR population (P = 0.045). CONCLUSION: Low pretreatment NLR patients are fit to undergo radical surgery with a substantial therapeutic benefit. Pretreatment NLR and PLR are independent predictors for patients with locally advanced ESCC located in the middle and upper esophagus who underwent radical surgery or dCRT. |
format | Online Article Text |
id | pubmed-7872927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78729272021-02-10 Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus Wang, Chen Tong, Jiaqi Tang, Mengqiu Lu, Yunyun Liang, Gaofeng Zhang, Zhanchun Chen, Tian Cancer Manag Res Original Research BACKGROUND: Various inflammatory biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), have been well authenticated to predict clinical outcomes in numerous types of cancer. The optimal treatment for patients with locally advanced esophageal squamous cell carcinoma (ESCC) located in the middle or upper region is still inconclusive. The aim of the study was to examine pretreatment NLR and PLR to select from radical surgery or definitive chemoradiotherapy (dCRT) for these patients. The linkage between pretreatment NLR/PLR and prognosis was also analyzed. METHODS: NLR and PLR were calculated in 113 locally advanced ESCC located in the middle or upper esophagus of patients who underwent radical surgery or dCRT between January 2014 and December 2019. A receiver operating characteristic curve was plotted to select the best cut-off value of NLR and PLR for predicting survival. A survival curve was plotted using the Kaplan–Meier method. Univariate and multivariate Cox regression analyses were applied to assess predictors for survival. RESULTS: NLR and PLR were associated with the extent of lymph node metastasis (NLR: P = 0.045; PLR: P = 0.002). Additionally, high PLR and recurrence with distant organ metastasis were closely related (P = 0.014), and NLR was related to the tumor stage (P = 0.043). The results of the multivariate analysis revealed that NLR (>2.07) and PLR (>183.06) were independently associated with poor prognosis. It is noteworthy that surgery was associated with a superior OS compared with dCRT in the low NLR population (P = 0.045). CONCLUSION: Low pretreatment NLR patients are fit to undergo radical surgery with a substantial therapeutic benefit. Pretreatment NLR and PLR are independent predictors for patients with locally advanced ESCC located in the middle and upper esophagus who underwent radical surgery or dCRT. Dove 2021-02-05 /pmc/articles/PMC7872927/ /pubmed/33574705 http://dx.doi.org/10.2147/CMAR.S294344 Text en © 2021 Wang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wang, Chen Tong, Jiaqi Tang, Mengqiu Lu, Yunyun Liang, Gaofeng Zhang, Zhanchun Chen, Tian Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus |
title | Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus |
title_full | Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus |
title_fullStr | Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus |
title_full_unstemmed | Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus |
title_short | Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus |
title_sort | pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors and reference markers of treatment options for locally advanced squamous cell carcinoma located in the middle and upper esophagus |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872927/ https://www.ncbi.nlm.nih.gov/pubmed/33574705 http://dx.doi.org/10.2147/CMAR.S294344 |
work_keys_str_mv | AT wangchen pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus AT tongjiaqi pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus AT tangmengqiu pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus AT luyunyun pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus AT lianggaofeng pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus AT zhangzhanchun pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus AT chentian pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus |